FULL INGREDIENTS: Water,Glycerin,Caprylic/Capric Triglyceride,Polyglycerin-3,Butylene Glycol,1,2-Hexanediol,Niacinamide,Methylpropanediol,Diglycerin,Laminaria Japonica Extract,Eclipta Prostrata Leaf Extract,Hydrogenated Lecithin,Ammonium Acryloyldimethyltaurate/VP Copolymer,Dipropylene Glycol,Acrylates/C10-30 Alkyl Acrylate Crosspolymer,Glutathione,Tromethamine,Ethylhexylglycerin,Hydrolyzed Sponge,Fructooligosaccharides,Adenosine,Beta-Glucan,Glyceryl Polymethacrylate,Hydrolyzed Hyaluronic Acid,Calcium Silicate,Sodium Silicate,Tocopherol,3-O-Ethyl Ascorbic Acid,Tocopheryl Acetate
These data suggest that a mGIPR-Ab/GLP-1 peptideantibody conjugate may act on a different population of cells or via distinct molecular mechanism(s) compared to GIPR agonists like tirzepatide
Recent advances in skin disorders: from basic mechanisms to therapies
The safest patient-friendly answer is: possibly, in selected patientsespecially those with existing diabetic retinopathy, especially early after starting treatment, and especially when glucose improves rapidly